Zerochymo-Forte Tablet contains Trypsin Chymotrypsin (100000 AU), a potent proteolytic enzyme combination used for its anti-inflammatory, fibrinolytic, and proteolytic properties. This medication is indicated for the management of acute and chronic inflammatory conditions, including postoperative swelling, trauma, and soft tissue injuries. Trypsin and chymotrypsin act by breaking down proteins involved in the inflammatory process, facilitating the reduction of edema, pain, and promoting faster healing. Zerochymo-Forte is particularly effective in reducing tissue inflammation and enhancing the absorption of hematomas and exudates. It is commonly prescribed as an adjunct therapy in conditions such as arthritis, sinusitis, and pharyngitis to alleviate symptoms and improve patient comfort. The enzyme activity of 100000 AU ensures optimal therapeutic efficacy while maintaining a favorable safety profile. Administration should be as directed by a healthcare professional, and it is generally well-tolerated with minimal adverse effects. Caution is advised in patients with hypersensitivity to proteolytic enzymes or those with bleeding disorders. Zerochymo-Forte Tablet offers a valuable therapeutic option for clinicians aiming to manage inflammation and accelerate tissue repair through enzymatic modulation.